The OptiScanner® 6000
The OptiScanner 6000 will represent the first step of platform expansion, with the goal of providing hospitals and healthcare practitioners with a single source that detects multiple analytes, all from the same micro-sample of blood.
The OptiScanner 6000 is the only automated, bedside blood monitoring system to accurately measure and trend plasma-based glucose and lactate, without the need for calibration.
It is well-proven that critically ill patients often suffer from stress-induced hyperglycemia, glycemic variability or hypoglycemia, which has been associated with increased morbidity and mortality in both diabetic and non-diabetic patients. Healthcare providers can use the OptiScanner to track a patient’s glucose in real-time and use trending data to detect changes earlier and aid in proactive decision making to help patients stay within the targeted glycemic range.
Current methodologies for measuring blood glucose in ICUs tend to be inaccurate, inconsistent and time-consuming.
The OptiScanner delivers plasma-based, bedside trending data without the need for calibration.
The OptiScanner Difference
Plasma Based – directly measures glucose levels in blood plasma - No Calibration – mid-infrared spectroscopy never requires time-consuming calibration, unlike reagent-based technologies Trending – automatically measures and trends glucose levels every 15 minutes, delivering an early warning system that supports proactive intervention.
The OptiScanner uses the world’s first zero dead-space connector as an interface between the patient’s IV line and the unit. This seamless connection with the distal port of any vascular access line eliminates the potential of heparin delivery to the patient. OptiScan Biomedical is expanding the OptiScanner platform to include additional metabolic and hemodynamic analytes using the same sample of blood.